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Abstract
Background: Folate deficiency is closely related to the development of neural tube defects (NTDs). However, the
exact mechanism is not completely understood. This study aims to induce murine NTDs by inhibiting one of the
folate metabolic pathways, de novo purine synthesis and preliminarily investigate the potential mechanisms. The
key enzyme, glycinamide ribonucleotide formyl transferase (GARFT) was inhibited by a specific inhibitor, lometrexol
(DDATHF) in the pregnant mice.
Methods: Pregnant mice were intraperitoneally injected with various doses of DDATHF on gestational day 7.5 and
embryos were examined for the presence of NTDs on gestational day 11.5. GARFT activity and levels of ATP, GTP,
dATP and dGTP were detected in embryonic brain tissue. Proliferation and apoptosis was analyzed by real-time
quantitative polymerase chain reaction (RT-qPCR), immunohistochemical assay and western blotting.
Results: 40 mg kg−1 body weight (b/w) of DDATHF caused the highest incidence of NTDs (30.8 %) and therefore
was selected as the optimal dose to establish murine NTDs. The GARFT activity and levels of ATP, GTP, dATP and
dGTP in embryonic brain tissue were significantly decreased after DDATHF treatment. Furthermore, Levels of
proliferation-related genes (Pcna, Foxg1 and Ptch1) were downregulated and apoptosis-related genes (Bax, Casp8
and Casp9) were upregulated. Expression of phosphohistone H3 was significantly decreased while expression of
cleaved caspase-3 was greatly increased.
Conclusions: Results indicate that DDATHF induced murine NTDs by disturbing purine metabolism and further
led to abnormal proliferation and apoptosis.
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Background
Neural tube defects (NTDs) are common, severe con-
genital malformations due to the failure of neural tube
closure during embryonic development [1, 2]. Studies
have shown that folate deficiency is closely related to
NTDs and that up to 50 to 70 % of NTDs can be pre-
vented by supplementation of folic acid [3–5]. However,
the mechanisms on how folate deficiency causes NTDs
still remained unclear. Besides, Heid et al. [6] controlled
the folate intake and showed that mouse embryos do
not develop NTDs. This indicates that folate deficiency
alone is not a cause of NTDs although it is certainly a
risk factor in humans and mice. In our previous study,
murine NTDs have been successfully induced by inhibit-
ing the key enzyme, DHFR, in folate metabolic pathway
[7]. We suppose that folate deficiency refers to folate
and folate related metabolic disorder, which may lead to
NTDs. Obviously, the inhibition of DHFR results in dys-
metabolism of THF and thus one carbon units. Decreased
one carbon units will affect biosynthesis of nucleotide and
the process of methylation, which may further impact
several in vivo physiological processes, including nucleic
acid metabolism, cellular proliferation and apoptosis.
Defects in any of these processes may lead to the occur-
rence of NTDs. Glycinamide ribonucleotide formyl
transferase (GARFT) is a key enzyme in the process of
de novo purine biosynthesis. It converts glycinamide ribo-
nucleotide (GAR) to glycinamide ribonucleotide formyl-
acid (FGAR) by using N-10-formyl-tetrahydrofolate as the
formyl donor [8]. Therefore, the inhibition of this enzyme
may impair the biosynthesis of purine nucleotide [9].
Lometrexol (dideazatetrahydrofolate, DDATHF) can in-
hibit the activity of GARFT by tightly binding with it and
further inhibit de novo purine synthesis, causing decreased
single purine nucleotide pool in cells, abnormal cell proli-
feration and apoptosis, even cell cycle arrest [10, 11].
Reports have shown that the occurrence of NTDs is associ-
ated with imbalance between cell proliferation and apop-
tosis. Studies have proved that disordered proliferation and
apoptosis in animal models of NTDs were induced by
hyperthermia [12], hyperglycemia [13], cyclophosphamide
[14], or methotrexate (MTX) [15]. Therefore, cell prolif-
eration and apoptosis have to be kept in dynamic balance
during the formation of neural tube. In the present study,
we aim to establish murine model of NTDs by using
DDATHF, and investigate the role of abnormal prolifera-
tion and apoptosis in the development of NTDs.
At present, NTDs induced by impairment of purine
nucleotide synthesis or inhibition of GARFT have not
been reported. This study aims to investigate whether
the murine model of NTDs can be induced by impairment
of purine biosynthesis via inhibition of GARFT using a




Chemicals and biochemical were purchased from Sigma-
Aldrich (Poole, Dorset, U.K.) unless otherwise indicated.
Establishment of murine NTDs by using DDATHF
All experimental procedures were reviewed and approved
by the Animal Ethics Committee of the Capital Institute
of Pediatrics. C57BL/6 mice (7–8 week, 18–20 g, Vital
River Laboratory, Beijing, China) were used in the experi-
ment. Mice were housed individually under controlled
conditions (22 °C, relative humidity 40 ~ 60 %, 12 h light/
dark cycle)-and with free access to food and water. Female
mice were mated with males overnight and vaginal plugs
were examined in the following morning. The presence of
vaginal plug in the pregnant mice was considered as gesta-
tional day 0.5. Pregnant mice were randomly divided into
seven groups. Six groups were treated with DDATHF
(Sigma-Aldrich, St. Louis, MO, USA) by intraperitoneal
injection on gestation day 7.5 [15, 30, 35, 40, 45 and
60 mg kg-1 body weight (b/w)]. The control group was
intraperitoneally injected with 0.9 % NaCl at the same
volume.
Examination of morphological and pathological changes
of embryos
Pregnant mice were sacrificed on gestation day 11.5. All
embryos were carefully dissected and examined under a
dissect microscope. The brain tissue in control group
from one litter (3–4 normal embryonic brain tissues)
was treated as a control sample, and that of NTD em-
bryos from one litter (3–4 NTD embryonic brain tis-
sues) was gathered as a NTD sample. All samples were
stored at −70 °C. The whole embryonic tissues were
Paraffin-embedded and cut into 5 μm thick slices ac-
cording to the procedures. The slices were then stained
with hematoxylin and eosin (H & E) and observed
under light microscope.
Detection of GARFT activities of embryonic tissue
The activity of GARFT was detected according to the
previous description with modifications [16]. Briefly, em-
bryos from sex litters (3–4 embryonic tissues per litter)
were collected respectively at 0, 6, 24, 48 and 96 h after
i.p. injecting of DDATHF (40 mg/kg body weight) at the
optimal dose. NTD embryonic brain tissues from one
litter were pooled as one sample for analysis. GARFT
protein of embryonic brain tissue was extracted using
the mammalian tissue lysis/extraction reagent (Sigma-
Aldrich). The concentrations of protein were determined
by Nanodrop 2000 (Thermo Scientific, Waltham, MA,
USA). GARFT activity was determined spectrophotomet-
rically at 298 nm. The extraction of embryonic brain tissue
(20 μg) wereincubated with 45 μmol of Tris-HCl (pH 7.5),
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90 μmol of 2-mercaptoethanol, 0.20 μmol of α, β-GAR
and 40 nmol of 10-formyltetrahydrofolate in 0.9 ml for
1 min at 30 °C. Routine assays were performed with
11 μM 10-formyl-5, 8-dideazafolic acid and 10 μM GAR.
One unit of enzyme activity represented the formation of
1 μmol product per minute.
Measurement of levels of ATP, GTP, dATP and dGTP by
HPLC
The content of ATP, GTP, dATP and dGTP in normal
and NTD embryonic brain tissue on gestation day 11.5
(3–4 embryos per litter as one sample) was measured by
high performance liquid chromatography (HPLC) as
described previously [17]. In brief, control and NTD
embryonic brain tissue were collected and placed on ice
and rapidly frozen in liquid nitrogen. The grinding
frozen tissue was mixed and incubated with ice-cold
trichloroacetic acid for 20–30 min, then centrifuged at
3000 × g (10 min, 4 °C). The supernatant was neutralized
with trichloroacetic acid in cold Freon. A portion of the
supernatant was used for HPLC detecting. Agilent Polaris
C18-a column was used for the detection (4.6 × 150 mm,
5 μm). The mobile phase was as follows: A: H2O,
10 mM tetrabutyl ammonium hydroxide (TBAH),
10 mM KH2PO4 (pH = 7); B: 10 mM TBAH, of metha-
nol (pH = 7). Gradient elution procedure was as follows:
0–30 min, 40 % B-60 % B; 30.1–60 min, 60 % B. Flow
rate: 1.0 ml/min, detection wavelength: 254 nm; injec-
tion volume: 50 μl, temperature of column: 25 °C.
Real-time quantitative polymerase chain reaction (RT-qPCR)
Total RNA from three control and three NTD embryonic
brain tissue on gestation day 11.5 were extracted by Trizol
reagent (Invitrogen, Carlsbad, CA, USA). The quantity of
RNA was determined by Nanodrop 2000 Spectrophotom-
eter at 260/280 nm. RT-qPCR was performed on the ABI
Prism 7900HT Sequence Detection System (Applied Bio-
systems, Foster City, California, USA) using Power SYBR
Green. Primers for the reaction were as follows: Pcna, For-
ward primer: 5′-TCAGGTACCTCAGAGCAAACG-3′,
Reverse primer: 5′-AAGTGGAGAGCTTGGCAATG-3′;
Foxg1, Forward primer: 5′-TGGCAAGGCATGTAGC
AAA-3′, Reverse primer: 5′-TCCACAGAACGCACC
CAC-3′; Ptch1, Forward primer: 5′-AATTCTCGACT
CACTCGTCCA-3′, Reverse primer: 5′-CTCCTCAT
ATTTGGGGCCTT-3′; Bax, Forward primer: 5′-GATC
AGCTCGGGCACTTTAG-3′, Reverse primer: 5′-TTG
CTGATGGCAACTTCAAC-3′; Casp8, Forward primer:
5′-TGCCCAGTTCTTCAGCAATA-3′, Reverse primer:





Immunohistochemical assay of PH3 and caspase-3
Three control and three NTD embryos on gestation day
11.5 formalin-fixed embryos were paraffin-embedded
and cut into 5 μm sections. The sections were dried on
a slide dryer at 58 °C for 1 h, then dewaxed and rehy-
draed by a series of xylol and ethanol rinses using the
Leica Autostainer XL (Leica Biosystems Nussloch
GmbH, Germany). The Dako antigen retrieval solution
was used for heat-activated antigen retrieval (pH 6.0)
(Dako, Glostrup, Denmark). The phosphohistone H3
(PH3) (Ser10) antibody (Cell Signaling, 1:400) and the
cleaved caspase-3 (Asp175) antibody (Cell Signaling,
Boston, MA, USA; 1: 250) were uesd to detect the pro-
liferation and apoptosis of neuroepithelial cells in the
sections. Six equal-sized fields were randomly selected
and the mean number of positive cells was counted
under light microscope.
Western blotting analysis for PH3 and caspase-3
The appropriate amount of CelLytic MT reagents (Sigma-
Aldrich, St. Louis, MO, USA) (20 ml of reagent for 1 g of
tissue) was added to embryonic brain tissues (3–4 embry-
onic brain tissues as one samples) respectively for protein
extraction. The samples were then transferred (with lysis/
extraction reagent) to a pre-chilled microhomogenizer
and centrifuged at 12,000 g for 10 min at 4 °C. The super-
natant was isolated and maintained at −80 °C. Protein
levels were determined by Nanodrop 2000 Spectropho-
tometer at 280 nm (Thermo Scientific, Waltham, MA,
USA). Proteins were separated by polyacrylamide gel elec-
trophoresis and transferred to polyvinylidene fluoride
membranes. After the SDS/PAGE, samples were placed in
5 % skim milk at room temperature for 1 h. The phospho-
histone H3 (PH3) (Ser10) antibody (Cell Signaling, 1:
1000) and the cleaved Caspase-3 (Asp175) antibody (Cell
Signaling, Boston, MA, USA; 1: 500) were added to the
membranes overnight at 4 °C. After that, anti-rabbit
secondary antibodies (1: 1000) were added at room
temperature for another 2 h. Detection was performed
using ECL reagent. Results were analyzed with a gel image
processing system.
Statistical analysis
Data were analyzed using SPSS16.0 software. GARFT ac-
tivity was analyzed using one-factor analysis of variance
(ANOVA), and the comparison between the control and
NTDs samples were examined by Student’s t-test. All of
the data were expressed as mean ± standard deviation
(x ± s). P < 0.05 was considered as statistically significant.
Results
Murine NTDs induced by DDATHF
Embryos were isolated and observed under a dissecting
microscope on gestational day 11.5. Results showed that
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with the increase of DDATHF doses, the rate of embry-
onic resorption and growth retardation increased. At the
dose of 60 mg/kg b/w DDATHF, all of the embryos were
resorbed. Meanwhile, the incidence of NTDs varies by
the treatment of different DDATHF doses. An ideal
animal model should have higher malformation rates
and lower mortality rate. At the dose of 40 mg kg/b/w,
embryos with NTDs showed the highest rate (30 %) with
a lower embryonic resorption rate (37.5 %). Based on this,
40 mg kg-1 b/w was selected as the optimal dose to estab-
lish NTDs model in the present study (Table 1).
Morphological and pathological changes of embryos after
DDATHF intervention
Neural tube defects (NTDs) are congenital malforma-
tions due to the failure of neural tube closure during
embryonic development, including anencephaly, spina
bifida and encephalocele. In this study, we observed the
difference of the phenotypes between the normal and
NTD embryo on gestational day 11.5 via stereoscopic
microscope. Then we investigated the tissue structure
characteritic of the normal and NTD brain by the
methods of H&E staining. From the level of anatomy,
the control embryo showed full appearance, normal for-
mation of forebrain, midbrain and afterbrain, smooth
and integrated surface of rachis, visible otic vesicle and
optic vesicle, curled and long thin tail (Fig. 1a, Add-
itional file 1: Figure S1). NTDs embryos showed exence-
phaly. Although forebrain, midbrain and hindbrain have
been formed, the margin were obscure. However, the
surface of rachis were smooth (Fig. 1b, Additional file 1:
Figure S1). H&E staining of normal embryos showed
neural tube full closure, lumen regular, neuroepithelial
cells arranged in neat rows (Fig. 1e, g). H&E staining of
NTDs embryos showed unfused neural tube hindbrain
apical plate which were wrapped by a layer of amniotic
membrane and stroma, irregular arranged neuroepithe-
lial cells (Fig. 1f, h). Besides, other malformations in-
cluding craniofacial abnormalities (Fig. 1c) and growth
retardations (Fig. 1d) were also observed.
GARFT activity decreased after DDATHF injection
GARFT activity in embryonic tissue of control and
DDATHF treated was detected at 0, 6, 24, 48 and
96 h after i.p. injection of optimal DDATHF dose on
gestational day 7.5 to confirm the effects of DDATHF
on de novo purine synthesis. Compared with the con-
trol embryo, GARFT activity was maximally inhibited
after at 6 h after DDATHF injection, and thereafter
gradually increased with time but remained signifi-
cantly lower than control even at 96 h. (Fig. 2a). The
result showed that GARFT activity was inhibited by
DDATHF.
Changes of ATP, GTP, dATP and dGTP levels after
DDATHF injection
ATP, GTP, dATP and dGTP levels were measured
using high performance liquid chromatography fol-
lowing DDATHF treatment at 0, 6, 24, 48 and 96 h,
respectively. Compared to control, levels of ATP, GTP,
dATP and dGTP of NTDs embryonic brain tissue de-
creased significantly at 6 h after DDATHF treatment,
and more significantly over time (Fig. 3). The changes
of ATP and GTP were more pronounced than dGTP
and dATP.
Analysis of proliferation and apoptosis by RT-qPCR
Samples of control (3–4 normal embryonic brain tis-
sues per litter as one sample) and NTDs group (3–4
NTD embryonic brain tissues per litter as one sam-
ple) had three biological replicates, respectively.
Proliferation-related genes (Pcna, Foxg1 and Ptch1) and
apoptosis-related genes (Bax, Casp8 and Casp9) were
measured to investigate the proliferation and apoptosis in
NTDs by RT-qPCR (Fig. 4). mRNA gel picture was pro-
vided as Additional file 2: Figure S2. Results showed that
compared to control group, expression of proliferation-
related genes were significantly decreased and expression
of apoptosis-related genes were significantly increased in
NTD groups.
Table 1 Embryonic phenotypes of mice treated by lometrexol (DDATHF)
DDTHF (mg kg−1) Litters (n) Embryos (n) Normal n (%) Resorption n (%) Growth retardation n (%) NTDs n (%) Other malformations n (%)
0 8 62 60 (96.8) 2 (3.2) 0 (0) 0 (0) 0 (0)
15 7 50 47 (94) 2 (4) 1 (2) 0 (0) 0 (0)
30 5 38 29 (76.3) 5 (13.2) 2 (5.3) 1 (2.6) 1a (2.6)
35 4 31 15 (48.4) 8 (25.8) 4 (12.9) 2 (6.5) 1a;1b (6.5)
40 9 65 8 (12.3) 21 (32.3) 14 (21.5) 20 (30.8) 2a (3.1)
45 5 34 2 (5.9) 21 (61.8) 9 (26.5) 2 (5.9) 0 (0)
60 4 29 0 (0) 29 (100) 0 (0) 0 (0) 0 (0)
NTDs neural tube defects
acraniofacial malformation
bpolydactyly
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Analysis of proliferation in neuroepithelial cells
To further verify the results of RT-qPCR, we performed
PH3 staining to assess the proliferation of neuroepithelial
cells by the use of immunohistochemical assay, which
showed that PH3 staining in NTD embryos (Fig. 5b)
was less obvious than that in control embryos (Fig. 5a)
(P < 0.05). Furthermore, the protein levels of PH3 in
embryonic brain tissue were analyzed by western blot
(Fig. 7a), and the results showed that the expression of
PH3 was significantly reduced.
Analysis of apoptosis in neuroepithelial cells
To investigate apoptosis in neuroepithelial cells,
Caspase-3 staining was performed using immunohisto-
chemical assay. The results revealed that staining of
Caspase-3 in NTD embryos (Fig. 6b) was more obvious
than that in the control embryos (Fig. 6a) (P < 0.05). We
also determined the expression levels of Caspase-3 pro-
tein in embryonic brain tissue using western blot. The
results showed that the expression of cleaved caspase-3
protein were significantly increased in embryonic brain
Fig. 1 Morphological changes of normal and abnormal embryos on gestational day 11.5 (a–d). Observation of embryonic development under a dissecting
microscope (Scale bars: 1 mm). a Normal embryos (from control group); b–d abnormal embryos from the lometrexol 40 mg/kg body weight group, the
NTD embryos showed failure closure of hindbrain of the neural tube (b, arrow), craniofacial malformation (c) and growth retardation (d) separately. e–h
Photomicrographs of coronal sections at the same plate of hindbrain (black lines in a and b) using hematoxylin and eosin staining (Scale bars: e, f 100 μm;
g, h 50 μm). (e, g) Normal embryos; (f, h) NTD embryos. g was magnifying (e). h was magnifying (f). exencephalycraniofacial malformation
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tissue of NTDs (Fig. 7b), which were consistent with the
RT-qPCR results. These results indicate that abnormal
proliferation and apoptosis exist in NTDs induced by
DDATHF.
Discussion
In the present study, NTDs were successfully induced by
disturbing purine metabolism via DDATHF. Pregnant
mice were intraperitoneally injected with DDATHF on
gestational day 7.5 and embryos were observed on gesta-
tional day 11.5. The group treated with 40 mg kg−1
DDATHF caused the highest incidence of NTDs (30.8 %)
with lowest lethality. Therefore, it was selected as the opti-
mal dose (40 mg/kg body weight) to establish murine
NTDs. As gestational day 7.5 is the critical period for
neural tube closure [18–20], lack of closure in the hind-
brain was primarily observed in embryos with NTDs. Ac-
cording to the opinion in Copp et al. [21], when closure
one fails, almost the entire neural tube from the midbrain
to the lower spine remains open, which is a condition
known as craniorachischisis. Embryos in which closure
two fails or is disrupted at the anterior or midbrain–hind-
brain neuropores, have exencephaly. The specific failure
of closure three leads to anencephaly that is confined to
the forebrain region, often in association with a split-face
malformation. In our results of exencephaly, closure two
or three was mainly affected. Craniofacial malformation
was caused by closure three failure. Besides, DDATHF
also caused growth retardation. These results indicate that
DDATHF induced congenital malformations, especially
NTDs. The study has investigated the effects of purine
dysmetabolism on the development of NTDs and we have
successfully established murine NTDs with a high inci-
dence of NTDs, which is in accordance with our aims.
DDATHF is a specific and classical inhibitor against
GARFT. GARFT is a key enzyme in the de novo synthe-
sis of purines without any inhibitory effects on enzymes
involved in folate synthesis and conversion [9, 22]. Poly-
glutamated form of DDATHF binds with GARFT 100
times more potently than DDATHF [23]. In the present
study, GARFT activity in embryonic brain tissue was ob-
viously decreased by DDATHF treatment and remained
significantly lower than control even at 96 h following
DDATHF administration. Levels of ATP, GTP, dATP and
dGTP in embryonic brain tissue were also significantly
reduced by DDATHF treatment. Purines are mainly used
for the biosynthesis of nucleic acids. Our results demon-
strate that DDATHF impaired the purine metabolism by
inhibition of GARFT, leading to the development of em-
bryonic malformations especially NTDs. The study has
provided direct evidence for the association between
purine dysmetabolism and NTDs for the first time. It
may be one of the mechanisms in folate deficient NTDs.
Impairment of purine biosynthesis via DDATHF may
affect neural tube closure by influencing cell apoptosis
and proliferation. During neural tube closure, cell
Fig. 2 Glycinamide ribonucleotide formyl transferase (GARFT) activities of embryonic brain tissues. DDATHF were intraperitoneally (I.P.) injected to
the pregnant mice at the optimal dose, 40 mg kg−1 body weight (b/w) on the gestation day 7.5. Embryonic brain tissue samples (3–4 embryonic
brain tissues as one sample) were collected according to the noted time. The GARTF activities were determined as described in Methods. Data
were expressed as means ± SD (n = 6). *P < 0.05, vs. GARFT activities of normal embryonic tissues
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Fig. 4 The mRNA expression of proliferation and apoptosis genes were measured by use of reverse transcription-quantitative polymerase chain
reaction. DDATHF were intraperitoneally (I.P.) injected to the pregnant mice at the optimal dose, 40 mg kg-1 body weight (b/w) on the gestation
day 7.5. Embryonic brain tissue samples were collected on the gestation day 11.5 *P < 0.05 NTDs versus control. NTDs, neural tube defects
Fig. 3 Histograms of time-dependent alterations of ATP, GTP, dATP and dGTP levels in embryonic brain tissue on gestation day 11.5. At the indicated time
after dosing (40 mg/kg body weight DDATHF), the samples (3–4 embryonic brain tissues as one sample) were collected and handled as described in Methods.
The black bars show are the control groups, the grey bars show the ATP, GTP, dATP, dGTP levels respectively of the DDATHF injected mice *P < 0.05
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differentiation, proliferation, apoptosis and other bio-
logical processes are necessary [24, 25]. Cell proliferation
and apoptosis need to maintain dynamic equilibrium
during the development of neural tube. If the equilib-
rium was broken, NTDs would occur. Purine dysmeta-
bolism may affect DNA, RNA synthesis, cell
proliferation and apoptosis. Recently, Xia Cong MM et
al. [26] found that increased expression of GARFT was
associated with promoted cell proliferation in liver
cancer. However, cell proliferation was inhibited as
GARTF was depleted evidenced by decreased expression
of proliferating cell nuclear antigen. Anthony Ng et al.
found that, Zygotic gart and paics mutants lead to pur-
ine dysmetabolism, ATP and GTP depletion and dis-
turbed DNA synthesis during S phase in the zebrafish
embryos. Besides, decreased proliferation and more
apoptosis were also found. These abnormalities ultim-
ately result in severe developmental defects [27]. Studies
Fig. 5 Immunostaining of PH3 in neuroepithelium from control and NTDs embryos on gestation day 11.5. a Immunostaining of PH3 in
neuroepithelium of hindbrain from control embryo; b immunostaining of PH3 neuroepithelium of hindbrain from NTD embryo; c quantification
of the number of PH3 positive cells. Bar = 100 μm. ▲ nfourth ventricle, *P < 0.05 NTDs versus control. NTDs, neural tube defects
Fig. 6 Immunostaining of activated caspase-3 in neuroepithelium from control and NTDs embryos on gestation day 11.5. a Immunostaining of
activated caspase-3 in neuroepithelium of hindbrain from control embryo; b immunostaining of activated caspase-3 in neuroepithelium of
hindbrain from NTD embryo; c quantification of the number of activated caspase-3 positive cells. Bar = 50 μm. ▲ fourth ventricle. *P < 0.05
NTDs versus control. NTDs, neural tube defects
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have indicated that DDATHF induced cell cycle arrest in
CEM and HL60 cells [28]. Our previous study have
found that Foxg1 and Ptch1 which are candidate genes
in NTDs were closely related to the development of
NTDs. We would like to identify whether Foxg1 and
Ptch1 express the same as our previous study. In the
study, mRNA levels of the proliferation-related genes
(Pcna, Foxg1 and Ptch1) were significantly decreased. Im-
munohistochemical assay and Western blot results
showed that the protein levels of PH3, a mitosis marker
for cell proliferation [29, 30], was also inhibited. These re-
sults suggest that cell proliferation was disturbed in NTDs
induced by purine dysmetabolism. Meanwhile, increased
expression of apoptosis related genes (Bax, Casp8 and
Casp9) and cleaved Caspase-3 in NTD embryonic brain
tissue indicates excess apoptosis in NTDs induced by
DDATHF. Furthermore, cells with positive immunohis-
tochemical stain of Caspase-3 increased in neuroepithe-
lial cells. These results implied that DDATHF may
cause NTDs through impairing the de novo synthesis
of purines and imbalance between proliferation and
apoptosis was involved in the development of NTDs.
Conclusions
DDATHF induced the serve birth defects in mice, espe-
cially NTDs. We have successfully established an animal
model of NTDs induced by purine dysmetabolism in the
present study. Abnormal cell proliferation and apoptosis
were found in the model, which was consistent with pre-
vious studies. Therefore, folate may act through purine
metabolism to affect neural tube development.
Additional files
Additional file 1: Figure S1. The development of control and DDATHF-
treated (40 mg/kg body weight) embryos on gestation day 11.5 observed
under a dissecting microscope. (A, B) the control embryos on gestational
day11.5; (C, D) embryos with NTDs .(B, D) The spine of control and NTD
embryos are closed well. (magnification 10×). (TIF 61 kb)




This study was supported by The Ministry of Science and Technology of China,
National “973” Project on Population and Health (Project 2013CB945404) and
The National Natural Science Foundation of China (Project 81370312).
Availability of data and materials
Not applicable.
Authors’ contributions
Conceived and designed the experiments: BN and XLT. Performed the
experiments: LX and LW. Analyzed the data: JHW and YG. Contributed
reagents/materials/analysis tools: ZQZ and GC. Wrote the paper: LX and LW.
All authors read and approved the final manuscript.
Competing interests
The authors declare that they have no competing interests.
Consent for publication
Not applicable.
Ethics approval and consent to participate
All experimental procedures were reviewed and approved by the Animal
Ethics Committee of the Capital Institute of Pediatrics.
Author details
1Department of Biotechnology, Beijing Municipal Key Laboratory of Child
Development and Nutriomics, Capital Institute of Pediatrics, Beijing 100020,
People’s Republic of China. 2Department of Biochemistry and Molecular
Fig. 7 Western blot analysis of PH3 (a) and activated caspase-3 (b) in control and embryos with NTDs in embryonic brain tissue on gestation day
11.5. NTDs, neural tube defects. Date were expressed as meas ± SD (n = 6)
Xu et al. Nutrition & Metabolism  (2016) 13:56 Page 9 of 10
Biology, Shanxi Medical University, Taiyuan 030001, People’s Republic of
China. 3Department of Cardiovascular Disease, Chinese PLA General Hospital
of Beijing Military Region, Beijing 100020, People’s Republic of China.
Received: 25 April 2016 Accepted: 9 August 2016
References
1. Yamaguchi Y, Miura M. How to form and close the brain: insight into the
mechanism of cranial neural tube closure in mammals. Cell Mol Life Sci.
2013;70:3171–86.
2. Xiao R, Yu HL, Zhao HF, Liang J, Feng JF, Wang W. Developmental
neurotoxicity role of cyclophosphamide on post-neural tube closure of
rodents in vitro and in vivo. Int J Dev Neurosci. 2007;25:531–7.
3. Greene ND, Copp AJ. Neural tube defects. Annu Rev Neurosci. 2014;37:221–42.
4. Zhang L, Ren A, Li Z, Hao L, Tian Y. Folate concentrations and folic acid
supplementation among women in their first trimester of pregnancy in a
rural area with a high prevalence of neural tube defects in Shanxi, China.
Birth Defects Res A Clin Mol Teratol. 2006;76:461–6.
5. Berry RJ, Li Z, Erickson JD, Li S, Moore CA, Wang H, Mulinare J, Zhao P,
Wong LY, Gindler J, Hong SX, Correa A. Prevention of neural-tube defects
with folic acid in China. China-U.S. Collaborative Project for Neural Tube
Defect Prevention. N Engl J Med. 1999;341:1485–90.
6. Heid MK, Bills ND, Hinrichs SH, Clifford AJ. Folate deficiency alone does not
produce neural tube defects in mice. J Nutr. 1992;122(4):888–94.
7. Zhao J, Guan T, Wang J, Xiang Q, Wang M, Wang X, Guan Z, Xie Q, Niu B,
Zhang T. Influence of the antifolate drug Methotrexate on the development
of murine neural tube defects and genomic instability. J Appl Toxicol. 2013;
33:915–23.
8. Smith GK, Mueller WT, Wasserman GF, Taylor WD, Benkovic SJ.
Characterization of the enzyme complex involving the folate-requiring
enzymes of de novo purine biosynthesis. Biochemistry. 1980;19(18):4313–21.
9. Beardsley GP, Moroson BA, Taylor EC, Moran RG. A new folate antimetabolite,
5,10-dideaza-5,6,7,8-tetrahydrofolate is a potent inhibitor of de novo purine
synthesis. J Biol Chem. 1989;264(1):328–33.
10. Sanghani SP, Moran RG. Tight binding of folate substrates and inhibitors
to recombinant mouse glycinamide ribonucleotide formyltransferase.
Biochemistry. 1997;36:10506–16.
11. Laohavinij S, Wedge SR, Lind MJ, Bailey N, Humphreys A, Proctor M,
Chapman F, Simmons D, Oakley A, Robson L, Gumbrell L, Taylor GA,
Thomas HD, Boddy AV, Newell DR, Calvert AH. A phase I clinical study of
the antipurine antifolate lometrexol (DDATHF) given with oral folic acid.
Invest New Drugs. 1996;14:325–35.
12. Edwards MJ. Review: Hyperthermia and fever during pregnancy. Birth
Defects Res A Clin Mol Teratol. 2006;76:507–16.
13. Chappell Jr JH, Wang XD, Loeken MR. Diabetes and apoptosis: neural crest
cells and neural tube. Apoptosis. 2009;14(12):1472–83.
14. Zhao H, Liang J, Li X, Yu H, Xiao R. Folic acid and soybean isoflavone
combined supplementation protects the post-neural tube closure
defects of rodents induced by cyclophosphamide in vivo and in vitro.
Neurotoxicology. 2010;31:180–7.
15. Wang X, Wang J, Guan T, Xiang Q, Wang M, Guan Z, Li G, Zhu Z, Xie Q,
Zhang T, Niu B. Role of methotrexate exposure in apoptosis and
proliferation during early neurulation. J Appl Toxicol. 2014;34(8):862–9.
16. Thorndike J, Kisliuk RL, Gaumont Y, Piper JR, Nair MG. Tetrahydrohomofolate
polyglutamates as inhibitors of thymidylate synthase and glycinamide
ribonucleotide formyltransferase in Lactobacillus casei. Arch Biochem
Biophys. 1990;277(2):334–41.
17. Krstulovic AM, Brown PR, Rosie DM, Champlin PB. High-performance
liquid-chromatographic analysis for tryptophan in serum. Clin Chem.
1977;23(11):1984–8.
18. Copp AJ. Neurulation in the cranial region–normal and abnormal. J Anat.
2005;207:23–635.
19. Greene ND, Copp AJ. Development of the vertebrate central nervous
system: formation of the neural tube. Prenat Diagn. 2009;29:303–11.
20. Copp AJ, Greene ND. Neural tube defects—disorders of neurulation and
related embryonic processes. Wiley Interdiscip Rev Dev Biol. 2013;2:213–27.
21. Copp AJ, Greene ND, Murdoch JN. The genetic basis of mammalian
neurulation. Nat Rev Genet. 2003;4(10):784–93.
22. Takimoto CH. New Antifolates: Pharmacology and Clinical Applications.
Oncologist. 1996;1:68–81.
23. Baldwin SW, Tse A, Gossett LS, Taylor EC, Rosowsky A, Shih C, Moran RG.
Structural features of 5,10-dideaza-5,6,7,8-tetrahydrofolate that determine
inhibition of mammalian glycinamide ribonucleotide formyltransferase.
Biochemistry. 1991;30:1997–2006.
24. Ybot-Gonzalez P, Cogram P, Gerrelli D, Copp AJ. Sonic hedgehog and
the molecular regulation of mouse neural tube closure. Development.
2002;129:2507–17.
25. Murdoch JN, Copp AJ. The relationship between sonic Hedgehog signaling,
cilia, and neural tube defects. Birth Defects Res A Clin Mol Teratol. 2010;
88:633–52.
26. Cong X, Lu C, Huang X, Yang D, Cui X, Cai J, Lv L, He S, Zhang Y, Ni R.
Increased expression of glycinamide ribonucleotide transformylase is
associated with a poor prognosis in hepatocellular carcinoma, and it
promotes liver cancer cell proliferation. Hum Pathol. 2014;45:1370–8.
27. Ng A, Uribe RA, Yieh L, Nuckels R, Gross JM. Zebrafish mutations in gart
and paics identify crucial roles for de novo purine synthesis in vertebrate
pigmentation and ocular development. Development. 2009;136:2601–11.
28. Sokoloski JA, Beardsley GP, Sartorelli AC. Induction of HL-60 leukemia cell
differentiation by the novel antifolate 5,10-dideazatetrahydrofolic acid.
Cancer Res. 1989;49:4824–8.
29 Zhong Q, Shi G, Zhang Q, Zhang Y, Levy D, Zhong S. Role of phosphorylated
histone H3 serine 10 in DEN-induced deregulation of Pol III genes and cell
proliferation and transformation. Carcinogenesis. 2013;34:2460–9.
30 Prigent C, Dimitrov S. Phosphorylation of serine 10 in histone H3, what for?
J Cell Sci. 2003;116:3677–85.
•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
Xu et al. Nutrition & Metabolism  (2016) 13:56 Page 10 of 10
